Citations

Showing 10 of 108104 citations.

A Rare Cause of Prevascular (Anterior) Mediastinal Mass
Schmidt, Walker, Hla, Diana, Araoz, Philip, Olson, Eric J., Pennington, Kelly M., Schmidt, Walker M. , Schmidt, Walker, Hla, Diana A. , Araoz, Philip, Olson, Eric J., Pennington, Kelly M.

Mayo Clinic

Annals of the American Thoracic Society | April 29, 2022 | Volume: 19 | Issue: 5 | Pages: 850-853

10.1513/annalsats.202109-1015cc | PMID 35486082 Get It

Evaluating the Effect of Multivalvular Disease On Mortality After Transcatheter Aortic Valve Replacement for Aortic Stenosis: A meta-analysis and Systematic Review
Siddiqi, Tariq Jamal , Usman, Muhammad , Shahid, Izza , Ahmed, Warda , Alkhouli, Mohamad , Usman, Muhammad Shariq , Ahmed, Jawad , Shahid, Izza , Alkhouli, Mohamad , Ahmed, Jawad

Mayo Clinic

Future Cardiology | April 29, 2022 | Volume: 18 | Issue: 6 | Pages: 487-496

10.2217/fca-2021-0061 | PMID 35485390 Get It

Effect of olfactory bulb pathology on olfactory function in normal aging
Tremblay, Cécilia , Intorcia, Anthony J., Sue, Lucia I., Wilson, Jeffrey R. , Shill, Holly A. , Driver‐Dunckley, Erika, Mehta, Shyamal H. , Beach, Thomas G. , Driver-Dunckley, Erika, Serrano, Geidy E. , Adler, Charles H. , Driver‐Dunckley, Erika

Mayo Clinic

Brain Pathology | April 29, 2022 | Volume: 32 | Issue: 5 | Pages: No page available

10.1111/bpa.13075 | PMID 35485279 Get It

AbstractDecline of olfactory function is frequently observed in aging and is an early symptom of neurodegenerative diseases. As the olfactory bulb (OB) is one of the first regions involved by pathology and may represent an early disease stage, we specifically aimed to evaluate the contribution of OB pathology to olfactory decline in cognitively normal aged individuals without parkinsonism or dementia. This clinicopathological study correlates OB tau, amyloid β (Aβ) and α‐synuclein (αSyn) pathology densities and whole brain pathology load to olfactory identification function as measured with the University of Pennsylvania Smell Identification Test (UPSIT) and clinical data measured proximate to death in a large autopsy study including 138 cases considered non‐demented controls during life. Tau pathology was frequently observed in the OB (95% of cases), while both Aβ (27% of cases) and αSyn (20% of cases) OB pathologies were less commonly observed. A weak correlation was only observed between OB tau and olfactory performance, but when controlled for age, neither OB tau, Aβ or αSyn significantly predict olfactory performance. Moreover, whole brain tau and αSyn pathology loads predicted olfactory performance; however, only αSyn pathology loads survived age correction. In conclusion, OB tau pathology is frequently observed in normally aging individuals and increases with age but does not appear to independently contribute to age‐related olfactory impairment suggesting that further involvement of the brain seems necessary to contribute to age‐related olfactory decline.
Validation of A Gene Expression Signature to Measure Immune Quiescence in Kidney Transplant Recipients in the Clia Setting
Cheung, Rocky, Xu, Hua, Jin, Xia, Tian, Wenlan, Bu, Lihong , Stone, Steven , Woodward, R. , Agrawal, Nikhil , Dholakia, Shamik , Phan, Ryan T., Tian, Wenlan, Pinney, Kevin

Mayo Clinic

Biomarkers in Medicine | April 29, 2022 | Volume: 16 | Issue: 8 | Pages: 647-661

10.2217/bmm-2022-0113 | PMID 35485169 Get It

Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Qu, Wenchun , Engelberg-Cook, Erica , Yan, Dan , Siddik, Abu Bakar , Bu, Guojun , Allickson, Julie, Kubrova, Eva , Hare, Joshua M. , Pascual, Jorge M., Nayfeh, Tarek , Saadi, Samer , Durvasula, Ravindra, Richards, Elaine M. , Sanfilippo, Fred , Siddik, Abu Bakar , Allickson, Julie G, Hare, Joshua M , Kurtzberg, Joanne , Mallea, Jorge M. , Durvasula, Ravindra V, Bu, Guojun , Nayfeh, Tarek , Saadi, Samer , Wang, Zhen , Caplan, Arnold I. , Ricordi, Camillo , Pepine, Carl J. , Rodríguez, Ricardo López , March, Keith L.

Mayo Clinic

Stem Cells Translational Medicine | April 29, 2022 | Volume: 11 | Issue: 7 | Pages: 688-703

10.1093/stcltm/szac032 | PMID 35640138 Get It

Abstract MSC (a.k.a. mesenchymal stem cell or medicinal signaling cell) cell therapies show promise in decreasing mortality in acute respiratory distress syndrome (ARDS) and suggest benefits in treatment of COVID-19-related ARDS. We performed a meta-analysis of published trials assessing the efficacy and adverse events (AE) rates of MSC cell therapy in individuals hospitalized for COVID-19. Systematic searches were performed in multiple databases through November 3, 2021. Reports in all languages, including randomized clinical trials (RCTs), non-randomized interventional trials, and uncontrolled trials, were included. Random effects model was used to pool outcomes from RCTs and non-randomized interventional trials. Outcome measures included all-cause mortality, serious adverse events (SAEs), AEs, pulmonary function, laboratory, and imaging findings. A total of 736 patients were identified from 34 studies, which included 5 RCTs (n = 235), 7 non-randomized interventional trials (n = 370), and 22 uncontrolled comparative trials (n = 131). Patients aged on average 59.4 years and 32.2% were women. When compared with the control group, MSC cell therapy was associated with a reduction in all-cause mortality (RR = 0.54, 95% CI: 0.35-0.85, I 2 = 0.0%), reduction in SAEs (IRR = 0.36, 95% CI: 0.14-0.90, I 2 = 0.0%) and no significant difference in AE rate. A sub-group with pulmonary function studies suggested improvement in patients receiving MSC. These findings support the potential for MSC cell therapy to decrease all-cause mortality, reduce SAEs, and improve pulmonary function compared with conventional care. Large-scale double-blinded, well-powered RCTs should be conducted to further explore these results.
Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond
Zanwar, Saurabh , Abeykoon, Jithma P.

Mayo Clinic

Therapeutic Advances in Hematology | April 29, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/20406207221093962 | PMID 35510210 Get It

Waldenström macroglobulinemia (WM) is an indolent lymphoplasmacytic lymphoma. Recent strides made in the genomic profiling of patients with WM have led to the identification of many novel therapeutic targets. Patients with WM can present with asymptomatic disease and not all patients require treatment. When criteria for initiating systemic therapy are met, the choice of therapy depends on the tumor genotype ( MYD88 and CXCR4 mutation status), patient preference (fixed versus continuous duration therapy, oral versus intravenous route, cost), associated medical comorbidities, and adverse effect profile of the treatment. In the absence of head-to-head comparison between chemoimmunotherapy and Bruton’s tyrosine kinase inhibitors in otherwise fit patients with a MYD88 L265P mutation, our preference is fixed duration therapy with four to six cycles of chemoimmunotherapy with bendamustine–rituximab. In this review, we discuss the role of MYD88 and CXCR4 mutation in treatment selection, and current data for frontline and salvage treatment options in patients with WM.
“A monument to suffering and to patience” : The harrowing journey of Nabby Adams through breast cancer
Jiménez, Rafael E.

Mayo Clinic

Journal of Medical Biography | April 29, 2022 | Volume: 31 | Issue: 2 | Pages: 133-142

10.1177/09677720221097792 | PMID 35484813 Get It

In 1813, Abigail “Nabby” Adams, the daughter of the second president of the United States, John Adams (1797–1801), passed away from metastatic breast cancer. Her ordeal began in 1810, at age 44, when she discovered a lump in her right breast She consulted with Dr Benjamin Rush, one of the most prominent physicians of the time and a signer of the Declaration of Independence, which resulted in a recommendation for an immediate mastectomy. The surgery was performed at her parent's home in Quincy, Massachusetts, by Dr John Warren. The crude and painful nature of the surgical procedure was highly traumatic to Ms. Adams and her family. After a few months, she returned to her home in rural New York. Within a few months she began feeling generalized pain. When it was evident that her symptoms were the result of disseminated breast cancer, she returned to her parents’ house, where she died on August 15, a mere 22 months after her surgery. Ms. Adams’ suffering through the stark treatment was the result of a unique historical period, when the medical community had just recently dismissed Galen's paradigms, but still lacked a basic knowledge of the disease's nature or the ability to administer painless, safe surgical treatment.
Bilateral Papilledema and Intact Vision With Normal Intracranial Pressure
Bhatti, M. Tariq , Chen, John J. , Swaminathan, Vishal , Chen, John J

Mayo Clinic

JAMA Ophthalmology | April 29, 2022 | Volume: 140 | Issue: 7 | Pages: 734

10.1001/jamaophthalmol.2022.0261 | PMID 35482298 Get It

Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma
Xu, Hongming , Jin, Yoon , Clemenceau, Jean R. , Choi, Jinhwan , Lee, Sung Hak , Kang, Jeonghyun , Hwang, Tae Hyun , Cha, Yoon Jin , Lee, Sung Hak

Mayo Clinic

The Journal of Pathology: Clinical Research | April 29, 2022 | Volume: 8 | Issue: 4 | Pages: 327-339

10.1002/cjp2.273 | PMID 35484698 Get It

Abstract This study aimed to explore the prognostic impact of spatial distribution of tumor‐infiltrating lymphocytes (TILs) quantified by deep learning (DL) approaches based on digitalized whole‐slide images stained with hematoxylin and eosin in patients with colorectal cancer (CRC). The prognostic impact of spatial distributions of TILs in patients with CRC was explored in the Yonsei cohort ( n = 180) and validated in The Cancer Genome Atlas (TCGA) cohort ( n = 268). Two experienced pathologists manually measured TILs at the most invasive margin (IM) as 0–3 by the Klintrup–Mäkinen (KM) grading method and this was compared to DL approaches. Inter‐rater agreement for TILs was measured using Cohen's kappa coefficient. On multivariate analysis of spatial TIL features derived by DL approaches and clinicopathological variables including tumor stage, microsatellite instability, and KRAS mutation, TIL densities within 200 μm of the IM (f_im200) remained the most significant prognostic factor for progression‐free survival (PFS) (hazard ratio [HR] 0.004 [95% confidence interval, CI, 0.0001–0.15], p = 0.0028) in the Yonsei cohort. On multivariate analysis using the TCGA dataset, f_im200 retained prognostic significance for PFS (HR 0.031 [95% CI 0.001–0.645], p = 0.024). Inter‐rater agreement of manual KM grading was insignificant in the Yonsei ( κ = 0.109) and the TCGA ( κ = 0.121) cohorts. The survival analysis based on KM grading showed statistically significant different PFS in the TCGA cohort, but not the Yonsei cohort. Automatic quantification of TILs at the IM based on DL approaches shows prognostic utility to predict PFS, and could provide robust and reproducible TIL density measurement in patients with CRC.
Abstract 9796: Atypical Right Atrial Flutter with Double Loop Reentry Involving the Cavotricuspid Isthmus and Superior Vena Cava with Successful Ablation
Minaskeian, Nareg , Javaid, Awad , Khetarpal, Banveet Kaur , Srivathsan, Komandoor

Mayo Clinic

Circulation | April 28, 2022 | Volume: 144 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.144.suppl_1.9796 Get It

Introduction: Atrial flutter (AFL) with figure-of-eight reentry (FOER) is effectively terminated by catheter ablation (CA) of the shared isthmus. Case: A 50-year-old man with prior mitral valve (MV) repair presented to our hospital with palpitations for 9 months refractory to metoprolol. ECG showed coarse atrial fibrillation at 61 bpm. Echocardiography showed left ventricular LVEF of 45%. Electrophysiology study revealed AFL (cycle length, TCL 290 msec) with a concentric activation pattern on the coronary sinus (CS) catheter, and a chevron pattern on the Halo catheter placed against the lateral tricuspid annulus (TA). Entrainment map revealed a near equal post-pacing interval and TCL in proximal CS, low lateral right atrium (RA), and CTI. Incomplete line of block was noted in the anterior wall of RA near the superior vena cava (SVC), likely from prior atriotomy scar. Double loop reentry (DLR) was demonstrated with one wavefront (WV) traveling counterclockwise around the TA using the CTI, and the other WV traveling posteriorly around the SVC (Figure). After CTI ablation, TCL changed from 290 msec to 330 msec suggesting blocked CTI. Now, the WV was a single loop around the SVC, confirmed by repeat activation mapping. Linear ablation from anterior TA to the anterior aspect of the SVC terminated the AFL. Differential pacing from either side of the anterior line and the CTI demonstrated a conduction time of > 200 msec and 150 msec in either direction, respectively. Decremental atrial pacing was unable to induce any arrhythmias. Discussion: FOER in this case is suggested by fusion of WVs in the lateral RA. The 2 circuits each had their own conduction gap, in the CTI and anterior RA wall near the SVC, respectively. DLR was proven by entrainment as well as activation mapping. The faster CTI-dependent AFL was entraining the upper loop reentry circuit. Conclusion: Atypical right AFL with DLR mimicking FOER was successfully terminated by CA of CTI and anterior line of ablation from TA to SVC.